Danielle Bitterman MD

@daniellebitterman.bsky.social

Leading AI for Clinical Trials at AstraZeneca | Physician | Previously Harvard Med & Mass General Brigham

“‘Just because you’re providing all of this information to language models,’ @daniellebitterman.bsky.social says, ‘doesn't mean they're effectively using that info in the same way that a physician would’. And once people upload this kind of data, they have limited control over how it is used.”🧪🛟

“Inaccurate information is a major concern; some studies have found that people without medical training obtain correct diagnoses from chatbots less than half the time. And uploading sensitive data adds privacy risks in exchange for responses that can feel more personalized.
Dr. Danielle Bitterman, an assistant professor at Harvard Medical School and clinical lead for data science and A.I. at Mass General Brigham, said it wasn't safe to assume a chatbot was personalizing its analysis of test results. Her research has found that chatbots can veer toward offering more generally applicable responses even when given context on specific patients.
"Just because you're providing all of this information to language models," she said,
"doesn't mean they're effectively using that information in the same way that a physician would."
And once people upload this kind of data, they have limited control over how it is used.”
Kashmir Hill@kashhill.bsky.social · 8mo ago

Dr. ChatGPT is learning even more about people than Dr. Google did www.nytimes.com/2025/12/03/w...

Check out our editorial on Zazzetti et al (2025)'s paper on synthetic data generation for breast cancer, in JCO CCI! Synthetic data could help with many gaps in clinical AI research, but challenges remain especially (IMO) issues with out-of-domain generalization @shan23chen.bsky.social

Jeremy Warner, MD, MS, FAMIA, FASCO@hemoncwarner.bsky.social · 9mo ago

Reimagining Evidence: Artificial Intelligence Synthetic Data Generation for Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI

An overemphasis on helpfulness makes LLMs vulnerable. Research shows models will comply with illogical medical requests, generating false information. This sycophantic tendency can be corrected with specific prompting and fine-tuning. #MedSky #MedAI #MLSky

When helpfulness backfires: LLMs and the risk of false medical information due to sycophantic behavior - npj Digital Medicine

npj Digital Medicine - When helpfulness backfires: LLMs and the risk of false medical information due to sycophantic behavior

nature.com

Are you driven to use AI to transform patient outcomes in oncology? My lab in the AI in Medicine Program (Mass General Brigham, Harvard Medical School) is seeking Postdoctoral Fellows to pioneer applications of AI—especially LLMs—in cancer care. More here: www.linkedin.com/posts/daniel...

🚀 Join Us at the Forefront of AI & Cancer Care | Danielle Bitterman

🚀 Join Us at the Forefront of AI & Cancer Care Are you driven to use cutting-edge AI to transform patient outcomes in oncology? My lab within the AI in Medicine Program (Mass General Brigham, Har...

linkedin.com

Exciting news: we are organizing a shared task – 2nd edition of the Chemotherapy Treatment Timelines Extraction from the Clinical Narrative (text mining task) -- collocated with the Clinical NLP Workshop. Do LLMs solve the task? Check out bit.ly/ChemoTimelin...

ChemoTimelines 2025

Treatment regimens are key details in understanding the effects of genetic, epigenetic, and other factors on tumor behavior and responsiveness. As precision oncology progresses, insights into the fine...

bit.ly

Conference and professional societies: PLEASE make hybrid options available for attendees and presenters at your conferences so that scientists from HHS-funded agencies can attend. These are unmissable opportunities to promote all the great intramural science and scientists from our government.

My Perspective in @NEJM_AI. AI could distort clinical decision-making in ways that prioritize profit over patient care. Oversight & regulation must go beyond performance metrics alone to address hidden commercial forces that could shape decision support. ai.nejm.org/doi/full/10....

Unseen Commercial Forces Could Undermine Artificial Intelligence Decision Support

Artificial intelligence (AI) is poised to transform health care, yet without robust safeguards, unseen commercial interests could distort care by prioritizing profit over patient well-being. The ph...

ai.nejm.org

My opinion as an actual NIH-funded researcher (unlike Vinay) at ucsf: his lies about how NIH dollars are used reflect a complete lack of understanding of how research is performed, a lack of respect for research, and are harmful to the entire biomedical research enterprise #grifter

Ryan Marino, MD@ryanmarino.bsky.social · last yr.

“Dr. Vinay Prasad, a Professor of Epidemiology and Biostatistics and Medicine at the University of California, San Francisco, praised the White House’s NIH's announcement.” Wonder how any actual researchers at UCSF feel to have a fascist weasel in their ranks selling them out?

As a cancer doctor I see every day how NIH-funded clinical trials save lives and has made the U.S. a leader in medical innovation. Here's one example: In the 1970s, childhood cancer survival was only 58%. Today it is 85%, largely thanks to NIH/NCI funding of Children's Oncology Group trials.

Bild

Senator Andy Kim just went to the USAID building, talked to the security guard there to confirm employees are being barred entry, and then did a press gaggle right there in front to call it out. This is doing something. This is making an effort on messaging. Other Democratic lawmakers: take notes.